Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Loading
Home›
Research›
Investment Firms›
Global Brain
AddedFeb 13, 2024
UpdatedJun 28, 2026
Global Brain

Global Brain

Operating

GB, a venture capital firm, fuels startups globally with hands-on growth support and innovation.

Location
Tokyo, Tokyo, JP
Founded
1998
Firm
Compare
Portfolio
Employees
News
Website

Investments

Zafrens
Zafrens

Total Raised

$29M

Rounds

3

Series A$23MDecember 2023
Hayden AI
Hayden AI

Total Raised

$103.3M

Rounds

7

Series BDecember 2023
Series B$53MJanuary 2023
SiLC Technologies
SiLC Technologies

Total Raised

$72.5M

Rounds

4

Series A$25MNovember 2023
Caelux
Caelux

Total Raised

$24M

Rounds

3

Series A$12MAugust 2023
Trove
Trove

Total Raised

$163.5M

Rounds

9

Series E$30MAugust 2023
ChromaCode
ChromaCode

Total Raised

$94M

Rounds

6

Series DJune 2023
Lokal
Lokal
Series B

Total Raised

$1.2B

Rounds

6

Series B$1.2BApril 2023
Neurable
Neurable
Series A

Total Raised

$9.8M

Rounds

12

Series AApril 2023
Regent
Regent

Total Raised

$87M

Rounds

5

Series UnknownMarch 2023
StructShare
StructShare

Total Raised

$8M

Rounds

2

Seed$8MMarch 2023
Switch Therapeutics
Switch Therapeutics

Total Raised

$52M

Rounds

1

Series A$52MMarch 2023
Shoulder Innovations
Shoulder Innovations

Total Raised

$112.9M

Rounds

6

Series D$42MMarch 2023
Toggle
Toggle

Total Raised

$14.8M

Rounds

4

Series A$3MFebruary 2023
Bakool
Bakool
Seed

Total Raised

$500k

Rounds

2

SeedDecember 2022
Sibros
Sibros

Total Raised

$85.5M

Rounds

5

Series UnknownNovember 2022
Omnichain
Omnichain

Total Raised

$3M

Rounds

4

Series Unknown$1MOctober 2022
Metalenz
Metalenz

Total Raised

$47.4M

Rounds

4

Series B$30MOctober 2022
Eclypsium
Eclypsium

Total Raised

$49M

Rounds

5

Series B$25MOctober 2022
Tailor
Tailor

Total Raised

$4.3M

Rounds

1

Seed$4.3MSeptember 2022
Neutral
Neutral

Total Raised

$16M

Rounds

3

Series A$12MAugust 2022
FidoCure®
FidoCure®
Series Unknown

Total Raised

$15.1M

Rounds

7

Series UnknownJuly 2022
Pente Networks
Pente Networks

Total Raised

$15M

Rounds

2

Series A$10MJune 2022
Deciduous Therapeutics
Deciduous Therapeutics

Total Raised

$16.5M

Rounds

3

Series UnknownJune 2022
Oobli
Oobli

Total Raised

$31.9M

Rounds

5

Series B$25MMay 2022